Trade Summary

3 days ago, Treace John T., serving as Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), purchased 115,520 shares at $2.95 per share, for a total transaction value of $340,588.69. Following this transaction, Treace John T. now holds 7,273,833 shares of TMCI.

This purchase represents a 1.61% increase in Treace John T.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:33 PM ET, 2 days after the trade was made.

TREACE MEDICAL CONCEPTS, INC. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.